James Dilley

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Medication adherence strategies for drug abusers with HIV/AIDS
    J L Sorensen
    San Francisco General Hospital, USA
    AIDS Care 10:297-312. 1998
  2. ncbi Residential detoxification for substance abusers with HIV/AIDS. Walden House Detoxification Program
    R Sargent
    Department of Psychiatry, UCSF at San Francisco General Hospital 94110, USA
    J Subst Abuse Treat 16:87-95. 1999
  3. ncbi Drug abuse treatment as an HIV prevention strategy: a review
    J L Sorensen
    Department of Psychiatry, Room 2117, Ward 21, Building 20, UCSF at San Francisco General Hospital, 1001 Potrero Avenue, San Francisco, CA 94110, USA
    Drug Alcohol Depend 59:17-31. 2000
  4. ncbi Bridging the gap between research and drug abuse treatment
    J L Sorensen
    Department of Psychiatry, University of California San Francisco, San Francisco General Hospital, 94110, USA
    J Psychoactive Drugs 32:379-82. 2000
  5. ncbi Case management for substance abusers with HIV/AIDS: a randomized clinical trial
    James L Sorensen
    Department of Psychiatry, San Francisco General Hospital, University of California, San Francisco, California, USA
    Am J Drug Alcohol Abuse 29:133-50. 2003
  6. ncbi HIV/hepatitis prevention in drug abuse treatment programs: guidance from research
    James L Sorensen
    University of California, San Francisco, San Francisco General Hospital, San Francisco, California 94110, USA
    Sci Pract Perspect 1:4-11. 2002
  7. ncbi Randomized trial of drug abuse treatment-linkage strategies
    James L Sorensen
    Department of Psychiatry, University of California, San Francisco, 94110, USA
    J Consult Clin Psychol 73:1026-35. 2005
  8. ncbi Comparison of three methods to measure HIV incidence among persons seeking voluntary, anonymous counseling and testing
    Timothy A Kellogg
    Department of Public Health, University of California, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 39:112-20. 2005
  9. ncbi Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges
    Gary L Humfleet
    University of California, San Francisco, 1426 Fillmore St, Suite 216, San Francisco, CA 94115, USA
    AIDS Educ Prev 21:54-64. 2009
  10. ncbi Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997-2000
    Gwendolyn P Hammer
    San Francisco Department of Public Health, San Francisco, California
    Sex Transm Dis 30:919-24. 2003

Collaborators

Detail Information

Publications13

  1. ncbi Medication adherence strategies for drug abusers with HIV/AIDS
    J L Sorensen
    San Francisco General Hospital, USA
    AIDS Care 10:297-312. 1998
    ..The paper aims to assist staff in drug treatment programmes to implement interventions that can increase adherence to medications for HIV/AIDS...
  2. ncbi Residential detoxification for substance abusers with HIV/AIDS. Walden House Detoxification Program
    R Sargent
    Department of Psychiatry, UCSF at San Francisco General Hospital 94110, USA
    J Subst Abuse Treat 16:87-95. 1999
    ..Data indicating the successes and limitations of the program are presented, along with recommendations for further addressing the needs of substance abuses with HIV/AIDS...
  3. ncbi Drug abuse treatment as an HIV prevention strategy: a review
    J L Sorensen
    Department of Psychiatry, Room 2117, Ward 21, Building 20, UCSF at San Francisco General Hospital, 1001 Potrero Avenue, San Francisco, CA 94110, USA
    Drug Alcohol Depend 59:17-31. 2000
    ..Future research should take into account patient self-selection processes and investigate other treatment modalities for heroin and stimulant abuse to determine their effects on HIV risk behaviors and HIV infection...
  4. ncbi Bridging the gap between research and drug abuse treatment
    J L Sorensen
    Department of Psychiatry, University of California San Francisco, San Francisco General Hospital, 94110, USA
    J Psychoactive Drugs 32:379-82. 2000
    ..This article reviews some of the differences and offers suggestions for institutional and personal changes to bring researchers and practitioners more into accord...
  5. ncbi Case management for substance abusers with HIV/AIDS: a randomized clinical trial
    James L Sorensen
    Department of Psychiatry, San Francisco General Hospital, University of California, San Francisco, California, USA
    Am J Drug Alcohol Abuse 29:133-50. 2003
    ..The study has limitations yet does not support the hypothesis that case management improves outcomes better than brief contact for this population...
  6. ncbi HIV/hepatitis prevention in drug abuse treatment programs: guidance from research
    James L Sorensen
    University of California, San Francisco, San Francisco General Hospital, San Francisco, California 94110, USA
    Sci Pract Perspect 1:4-11. 2002
    ..Some activities can be accomplished by providers simply becoming aware of the issues; others will require significant infusion of leadership, education, and fiscal support...
  7. ncbi Randomized trial of drug abuse treatment-linkage strategies
    James L Sorensen
    Department of Psychiatry, University of California, San Francisco, 94110, USA
    J Consult Clin Psychol 73:1026-35. 2005
    ..Case management and vouchers can be valuable in health settings to link substance abusers with medical problems to drug abuse treatment...
  8. ncbi Comparison of three methods to measure HIV incidence among persons seeking voluntary, anonymous counseling and testing
    Timothy A Kellogg
    Department of Public Health, University of California, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 39:112-20. 2005
    ..The authors compared 3 practical methods to estimate human HIV incidence rates using existing data from persons seeking anonymous testing in San Francisco between 1996-2002. Each method was assessed for strengths and limitations...
  9. ncbi Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges
    Gary L Humfleet
    University of California, San Francisco, 1426 Fillmore St, Suite 216, San Francisco, CA 94115, USA
    AIDS Educ Prev 21:54-64. 2009
    ..Both licit and illicit drug use was common and there were significant rates of lifetime psychiatric diagnoses in this cohort of smokers. It is critical to evaluate interventions that consider the specific needs of this group...
  10. ncbi Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997-2000
    Gwendolyn P Hammer
    San Francisco Department of Public Health, San Francisco, California
    Sex Transm Dis 30:919-24. 2003
    ..The rate of sexual transmission of hepatitis C virus (HCV) is debated...
  11. ncbi Recent HIV-1 infection detection: comparison of incidence estimates derived by laboratory assays and repeat testing data
    Hong Ha M Truong
    Department of Medicine, University of California, San Francisco, San Francisco, CA 94105, USA
    J Acquir Immune Defic Syndr 51:502-5. 2009
    ..We compared HIV-1 incidence estimates derived from 3 different methods: Vironostika-less sensitive, BED capture enzyme immuno assay (BED-CEIA), and repeat testing history...
  12. ncbi Do people who develop AIDS within 12 months of HIV diagnosis delay HIV testing?
    Sandra K Schwarcz
    San Francisco Department of Public Health, 25 Van Ness Ave, Ste 500, San Francisco, CA 94102, USA
    Public Health Rep 126:552-9. 2011
    ..However, studies evaluating this definition have not been conducted. We measured the degree of misclassification of delayed testing based on this surveillance definition of late testing...
  13. ncbi Risk of HIV infection attributable to oral sex among men who have sex with men and in the population of men who have sex with men
    Kimberly Page-Shafer
    Center for AIDS Prevention Studies, Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    AIDS 16:2350-2. 2002
    ..PAR%, based on the number of fellatio partners, ranges from 0.10% for one partner to 0.31% for three partners. The risk of HIV attributable to fellatio is extremely low...